GL1X · GenesisL1 explorer

MolNFT v1 · #134663 · protein

Crystal structure of plasmodium falciparum dihydroorotate dehydrogenase bound with inhibitor DSM421

5TBO: “Crystal structure of plasmodium falciparum dihydroorotate dehydrogenase bound with inhibitor DSM421”. X-ray diffraction, 3 ligands (78Z, FMN, ORO). MolNFT v1 #134663 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
5TBO
Type
protein
Length
362 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
UniProt
Q08210
Ligands
78Z, FMN, ORO

Structure

x-ray diffraction · 1 distinct chain.

ChainMoleculeTypeResiduesSecondary structureUniProt
A—protein362—Q08210

Ligands and binding sites

  • 78Z · 2-(1,1-difluoroethyl)-5-methyl-N-[6-(trifluoromethyl) pyridin-3-yl][1,2,4]triazolo[1,5-a]pyrimidin-7-amine · ligand · chains A
  • FMN · Flavin mononucleotide · ligand · chains A
  • ORO · Orotic acid · ligand · chains A
  • GOL · Glycerol · additive · 2 copies · chains A
  • LDA · Lauryl dimethylamine-N-oxide · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Compared structures

  • Q08210 · AlphaFold monomer V2.0 prediction for dihydroorotate dehydrogenase (quinone)… · a predicted model of the same protein · chain A against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.